|
Getting your Trinity Audio player ready...
|
A new group of stocks under $5 is gaining traction among investors as merger discussions, strategic reviews, and aggressive trading activity signal a potential high-beta small-cap momentum cycle heading deeper into 2026.
From semiconductor consolidation themes to medical technology acquisition setups and emerging AI infrastructure plays, several names are now appearing on active trader and investor watchlists.
AI Infrastructure Breakout: Blaize Holdings (NASDAQ: BZAI) Delivers Explosive Growth
A series of powerful developments across artificial intelligence, biotech, and capital markets is helping define where momentum is building — and Blaize Holdings Inc. (NASDAQ: BZAI) is emerging as one of the most compelling AI infrastructure stories.
The company reported full-year 2025 revenue of $38.6 million, a dramatic increase from $1.6 million in 2024, highlighting accelerating demand for AI inference infrastructure. Quarterly growth showed a sharp ramp, scaling from approximately $1 million in Q1 to $23.8 million in Q4, reflecting rapid adoption.
The surge aligns with a broader industry shift away from AI model training toward real-world deployment, where:
- Power efficiency
- Cost per inference
- Scalable edge-AI infrastructure
are becoming critical differentiators.
With partnerships spanning cloud providers, sovereign AI initiatives, and industrial applications, and an AI services platform expected in Q2, Blaize is positioning itself at the center of the next phase of AI monetization — an area gaining increasing investor focus.
ENDRA Life Sciences (NASDAQ: NDRA): Strategic Alternatives Signal Acquisition Potential
Meanwhile, ENDRA Life Sciences Inc. (NASDAQ: NDRA) has initiated a review of strategic alternatives aimed at maximizing shareholder value.
This type of move is often associated with potential outcomes such as:
- Strategic partnerships
- Licensing agreements
- Acquisition scenarios
ENDRA’s TAEUS® imaging technology, focused on early detection and monitoring of steatotic liver disease (SLD), aligns with a rapidly expanding healthcare market. With increasing investment into metabolic disease treatments, scalable diagnostic platforms like ENDRA’s could become attractive targets for larger healthcare or pharmaceutical companies.
Peraso (NASDAQ: PRSO) and Mobix Labs (NASDAQ: MOBX): Merger Discussions Drive Attention
Leading the group is Peraso Inc. (NASDAQ: PRSO), which has already captured market attention following its high-volume breakout and defense-tech catalyst tied to 60GHz mmWave communications.
Now, ongoing merger discussions with Mobix Labs Inc. (NASDAQ: MOBX) are adding a new layer of upside speculation.
Mobix Labs, known for its advanced RF, connectivity, and next-generation wireless solutions, represents a potential strategic fit alongside Peraso’s mmWave semiconductor platform. A combination could:
- Expand capabilities across 5G, defense, and AI connectivity markets
- Strengthen positioning in high-frequency semiconductor infrastructure
- Create scale in emerging mmWave and RF applications
With both companies aligned to future connectivity infrastructure, investors are beginning to view PRSO as a potential consolidation play within the semiconductor sector.
Speculative Momentum Builds: ITOC and ORBS Attract Early Interest
Alongside PRSO, NDRA, and BZAI, additional speculative small-cap names are seeing increased activity:
- iTonic Holdings Ltd (NASDAQ: ITOC)
- Eightco Holdings Inc. (NASDAQ: ORBS)
Eightco Holdings (NASDAQ: ORBS) is emerging as a speculative trading play, attracting attention from momentum investors seeking exposure to low-float, high-volatility opportunities within evolving technology and digital ecosystems.
These types of stocks often move quickly when volume enters, making them a focus for short-term traders and high-risk, high-reward strategies.
Capital Rotation Into Under-$5 Catalyst Stocks
The convergence of:
- Merger speculation (PRSO + MOBX)
- Strategic review / acquisition potential (NDRA)
- AI infrastructure growth (BZAI)
- Speculative trading activity (ITOC, ORBS)
signals a broader rotation into small-cap, catalyst-driven equities.
Investors are increasingly targeting:
- $3 Stocks and under
- Low-float setups
- Clear catalysts (M&A, revenue growth, sector momentum)
- Exposure to major themes (AI, semiconductors, healthcare, defense)
Bottom Line
With Peraso (NASDAQ: PRSO) gaining traction on merger discussions with Mobix Labs (NASDAQ: MOBX), ENDRA Life Sciences (NASDAQ: NDRA) potentially positioning for a future acquisition, and Blaize Holdings (NASDAQ: BZAI) delivering explosive AI-driven revenue growth, the stocks under $5 category is heating up.
Add in speculative momentum from names like ITOC and ORBS, and a clear pattern is emerging: capital is beginning to flow back into high-risk, high-upside small-cap opportunities tied to some of the market’s most powerful themes.
For investors scanning for early-stage opportunities in 2026, this group represents a cluster of momentum + catalyst-driven stocks now firmly on the radar.